FundedIQ
Biotechnology

MyoGene Bio: Funding, Investors & Team (Oct 2026)

MyoGene Bio develops therapies for muscle diseases, starting with a gene-editing therapy for Duchenne muscular dystrophy.

www.myogenebio.com Los Angeles, United States 1-10 employees
Biotechnology Genetics Health Care Therapeutics Wellness
Total raised
$400k
Rounds
2
Latest
Undisclosed round
Nov 2025

MyoGene Bio has raised $400k across 2 funding rounds on record, the most recent an undisclosed round of $400k announced in Nov 2025.

That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

MyoGene Bio Company Profile and Key Stats

Total funding raised
$400k
across 2 rounds on record
Funding rounds on record
2
1 with no disclosed amount
Latest funding round
Undisclosed round
$400k in Nov 2025
Employees
1-10
reported band
Headquarters
Los Angeles, United States

Latest funding round on record: Nov 2025.

MyoGene Bio Funding Rounds

Date
Round
Amount
Undisclosed round
$400k
Undisclosed round
Undisclosed

1 of 2 rounds was announced without a disclosed amount and is excluded from the total.

MyoGene Bio announced an undisclosed round in May 2023; the amount was not disclosed.

2.5 years later, an undisclosed round of $400k was announced in Nov 2025.

MyoGene Bio Founders and Leadership Team

Name
Role
Contact
Courtney Young
Founder
—
Eric Camino
—
Locked

Contact details for the MyoGene Bio team: 1 has a LinkedIn profile.

Start 14-day free trial →

MyoGene Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

MyoGene Bio's latest round of $400k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like MyoGene Bio in Biotechnology and Los Angeles

Companies Similar to MyoGene Bio

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

MyoGene Bio Funding FAQs

What does MyoGene Bio do?

MyoGene Bio develops therapies for muscle diseases, starting with a gene-editing therapy for Duchenne muscular dystrophy.

How much funding has MyoGene Bio raised?

MyoGene Bio has raised $400k across 2 rounds on record. The most recent is an undisclosed round of $400k announced in Nov 2025.

When did MyoGene Bio last raise funding?

MyoGene Bio's most recent funding round on record is an undisclosed round of $400k, announced in Nov 2025.

Who founded MyoGene Bio?

FundedIQ lists Courtney Young (Founder) at MyoGene Bio.

Where is MyoGene Bio headquartered?

MyoGene Bio is based in Los Angeles, California, United States.

How many employees does MyoGene Bio have?

MyoGene Bio is in the 1-10 employee band.

How does MyoGene Bio's funding compare to other Biotechnology startups?

MyoGene Bio's latest round of $400k is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's MyoGene Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MyoGene Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.